Cannabinoid receptor ligands

Details for Australian Patent Application No. 2008290325 (hide)

Owner AstraZeneca AB

Inventors Johnstone, Shawn; Page, Daniel; Liu, Ziping; Brown, William; Yue, Shi Yi; Beha, Sara; Tomaszewski, Miroslaw; Wei, Zhong-Yong

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008290325

PCT Pub. Number WO2009/024819

Priority 60/956,478 17.08.07 US

Filing date 15 August 2008

Wipo publication date 26 February 2009

International Classifications

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/024819 Priority application(s): WO2009/024819

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008290327-Oxadiazole derivatives as DGAT inhibitors

2008290316-Naked collation package